Sending Office: Honorable Paul Tonko
Endorsed by the Bipartisan Heroin Taskforce
Organizational Support: Coalition to Stop Opioid Overdose, American Society of Addiction Medicine, American College of Obstetricians and Gynecologists, American Nurses Association, American Association of Nurse Practitioners,
American Academy of Physician Assistants, American College of Nurse-Midwives, American Association of Nurse Anesthetists, National Association of Clinical Nurse Specialists, American Association of Colleges of Nursing
Cosponsors: Bonamici, Carson,
Clark, Clarke, Coffman, Collins, Comstock, Curtis,
Dingell, Engel, Eshoo, Faso, Fitzpatrick,
Higgins, Jayapal, Kaptur, Kennedy, King, Kuster, Lance,
Larson, Lujan Grisham, Matsui, MacArthur, McKinley,
McNerney, Moulton, Murphy, Norcross, Norton, Raskin, Roybal-Allard, Schakowsky, Sensenbrenner,
Sinema, Shea-Porter, Slaughter, Soto, Stefanik,
Suozzi, Glenn Thompson, Tipton, Turner, Yarmuth
The United States continues to be in the midst of a devastating opioid epidemic. 2016 was the deadliest year yet, with more than 64,000 dying from drug overdoses according to the Centers for Disease Control, an astonishing 21 percent increase from 2015.
Despite the passage of the Comprehensive Addiction and Recovery Act, which represented a good first step, there is still a significant shortage in treatment capacity, resulting in individuals waiting months or years to receive effective addiction treatment.
Only 20 percent of patients who need treatment for opioid use disorder are currently receive it.
The Addiction Treatment Access Improvement Act builds on the steps taken in the Comprehensive Addiction and Recovery Act to further expand addiction treatment capacity by expanding the list of providers eligible to prescribe buprenorphine, an office-based
form of medication-assisted treatment, to include clinical nurse specialists, certified nurse midwives, and certified registered nurse anesthetists. These advanced practice nursing professionals have similar educational and training requirements as other currently
eligible providers and serve as primary care providers for vulnerable populations, such as pregnant and postpartum women.
In addition, this legislation would codify the 2016 regulation that expanded the number of patients qualified physicians could treat to 275, while preserving the ability of the HHS Secretary to adjust the patient limit, and make permanent the authorization
that allows non-physician providers to treat patients with buprenorphine.
These commonsense steps will expand our addiction treatment workforce and help save lives today. For more information or to cosponsor, please contact Jeff Morgan in my office at
Paul D. Tonko
Member of Congress
e-Dear Colleague version 2.0